Identification and characterization of nuclear factor κB binding sites in the murine bcl-x promoter

Journal of Neurochemistry

Volumn 75, Issue 4, 2000, Pages 1377-1389

  Glasgow, J N ^a,b   Wood, T ^a,b   Perez Polo, J R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Apoptosis; Bcl x; Nuclear factor B; Promoter; Transcription

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL X; SYNAPTOTAGMIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

5' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BINDING SITES; BINDING, COMPETITIVE; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PC12 CELLS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECOMBINANT PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSFECTION;

ANIMALIA; MURINAE;

EID: 0033811795     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0751377.x     Document Type: Article

References (71)

1. Structure of the cyclo-oxygenase-2 gene
2. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: Evidence for involvement of a kappa B-binding factor and attenuation of peroxide and calcium accumulation
3. Physical interactions between Ets and NF-kappa B/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells
4. An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
5. Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-kappa B
6. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
7. Coupling of a signal response domain in I kappa B-alpha to multiple pathways for NF-kappa B activation
8. Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia
9. Conversion of Bcl-2 to a Bax-like death effector by caspases
10. Cloning and structural analysis of cDNAs for bcl-2, and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
11. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor kappa B in rats
12. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
13. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 alpha chain genes
14. Bcl-Xshort is elevated following severe global ischemia in rat brains
15. Dimerization of NF-kappa B2 with Re1A (p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD3)
16. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line
17. NF-kappaB to the rescue: RELs, apoptosis, and cellular transformation
18. Function and expression of the Bcl-x gene in the developing and adult nervous system
19. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes
20. Bcl-w, a novel member of the bcl-2 family, promotes cell survival
21. Bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria
22. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent cell death
23. High efficiency DNA-mediated transformation of primate cells
24. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
25. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-XL expression
26. Nuclear factor kappa B/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction
27. Genomic organization, promoter analysis, and chromosome localization of the mouse bcl-x gene
28. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while Bcl-xL prevents this release but not tumor necrosis factor-R1/Fas death
29. An essential role for nuclear factor kappa B in promoting double positive thymocyte apoptosis
30. Cytosol-to-membrane redistribution of Bax and Bcl-xL during apoptosis
31. Bcl-2 phosphorylation required for anti-apoptosis function
32. NF-kappa B mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
33. Purified bovine NF-kappa B recognizes regulatory sequences in multiple genes expressed during activation of T- and B-lymphocytes
34. High constitutive NF-kappa B activity mediates resistance to oxidative stress in neuronal cells
35. Differential transcriptional activation in vitro by NF-kappa B/Re1 proteins
36. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system
37. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation
38. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites
39. Bcl-2 related protein expression in apoptosis: Oxidative stress versus serum deprivation in PC12 cells
40. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development
41. Inhibition of transient gene expression in Chinese hamster ovary cells by cyclobutane dimers and (6-4) photoproducts in transfected ultraviolet-irradiated plasmid DNA
42. Massive ceil death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
43. Nuclear factor kappa B, a mediator of lipopolysaccharide effects
44. NF-kappa B: A crucial transcription factor for glial and neuronal cell function
45. Cell death during development of the nervous system
46. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons
47. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation
48. A cooperative interaction between NF-kappa B and Sp-1 is required for HIV-1 enhancer activation
49. An interaction between DNA binding-domains of Re1Ap65 and Sp-1 mediates human immunodeficiency virus activation
50. Social controls on cell survival and cell death
51. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65
52. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
53. The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism
54. Erythropoietin can induce the expression of Bcl-XL through Stat5 in erythropoietin-dependent progenitor cell lines
55. Transcription initiation from TATA-less promoters within eukaryotic protein coding genes
56. The 'Initiator' as a transcription control element
57. Rel/NF-kappa B transcription factors and the control of apoptosis
58. Involvement of Ets, rel, and Sp-1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages
59. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-kappa B activation in primary hippocampal neurons
60. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter
61. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma
62. Suppression of TNF-alpha-induced apoptosis by NF-kappa B
63. Innovative treatment programs against cancer
64. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
65. I kappa B proteins: Structure, function and regulation
66. Movement of Bax from the cytosol to the mitochondria during apoptosis
67. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress
68. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells
69. IEX-1L, an apoptosis inhibitor involved in NF-kappa B-mediated cell survival
70. Bad, a heterodimeric partner of Bcl-xL and Bcl-2, displaces Bax and promotes cell death
71. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3- not Bcl-xL